期刊文献+

凝血因子Ⅷ质量检测异常的应急应用 被引量:1

Emergency measures against abnormal quality detection of coagulation factor Ⅷ
下载PDF
导出
摘要 目的探讨凝血因子Ⅷ检测异常(检测结果不符合预期)时的应急应用措施,分析检测试剂可靠性。方法选取试剂A和试剂B 2个厂家,从定标和质控、批内不精密度试验、准确度试验、携带污染试验、线性范围试验、不同厂家试剂或不同实验室检测结果对比等多方面进行试验验证。结果检测结果显示定标和质控、批内不精密度试验、准确度试验、携带污染试验2家试剂均符合要求;对人类新鲜血浆检测,试剂A和试剂B检测结果均在正常范围(P<0.01),试剂A检测结果低于试剂B;对冷沉淀凝血因子、原料新鲜血浆和各自质控品检测,2个外单位实验室检测结果与试剂B相符合,试剂A结果明显偏低;试剂B线性范围验证符合要求。结论试剂A目前暂时不能用于血标本和血液制品中Ⅷ因子检测,试剂B符合使用要求。厂家提供的质控品不是唯一的判断标准,当检测结果异常时,应该更换其他厂家试剂对比测定,亦可送外单位实验室同时平行检测,比较检测结果是否存在偏差。 Objective To explore the emergency measures when coagulation factorⅧdetection do not meet the expectation,and analyze the reliability of detection reagents.Methods Reagent A and Reagent B from two manufacturers were selected for test and verification in terms of calibration and quality control,intra batch imprecision test,accuracy test,carryover contamination test,linear range test,and comparison of test results of reagents from different manufacturers or laboratories.Results The results showed that calibration and quality control,intra batch imprecision test,accuracy test and carryover contamination test of Regeat A and B both met the requirements;the test results of Reagent A,presenting lower results than Reagent B,were found to be in required limits for human fresh plasma(P<0.01);the test results of two laboratories outside our blood station were in full accordance with that of Reagent B when detecting cryoprecipitated antihemophilic factors,raw material fresh plasma and their respective quality control products,whereas Reagent A presented significantly lower results.The linear range of Reagent B met the requirements.Conclusion The detection ability targeted at factor VIII in blood samples and blood products can be reached by Reagent B,but not Reagent A at present.The quality control products provided by the manufacturer are not the only criterion.Using other manufacturers′reagents for comparative tests,or sending to laboratories outside the unit for parallel tests could be adopted when there are abnormal test results.
作者 林惠燕 孙爱农 何锐洪 葛峰 郑晓兰 方育如 LIN Huiyan;SUN Ainong;HE Ruihong;GE Feng;ZHENG Xiaolan;FANG Yuru(Zhongshan Central Blood Station,Zhongshan,528400,China)
机构地区 中山市中心血站
出处 《中国输血杂志》 CAS 2020年第12期1297-1300,共4页 Chinese Journal of Blood Transfusion
关键词 血液质量 凝血因子Ⅷ 异常 应急应用 blood quality coagulation factorⅧ abnormality emergency application
  • 相关文献

参考文献6

二级参考文献39

  • 1敖必蓉,周全昌,李坤.各种不同凝血活酶试剂测定凝血酶原时间的研究[J].血栓与止血学,2006,12(3):129-131. 被引量:3
  • 2秦晓光.“检查结果互认”和质量管理[J].中华检验医学杂志,2007,30(2):132-135. 被引量:45
  • 3杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 4王治国.临床检验方法确认与性能评价[M].北京:人民卫生出版社,2009:12.
  • 5梁远,林发全,李明芬.血凝仪的不同检测系统对凝血四项检测结果的可比性研究[J].医学综述,2007,13(23):1824-1826. 被引量:6
  • 6中华人民共和国卫生部.WS/T406-2012临床血液学检验常规项目分析质量要求[S].北京:中国标准出版社,2012.
  • 7U.S. Department of Health and Human Services. 42 CFR Part 493 medicare, medicaid and CLIA programs; Laboratory requirements relating to quality systems and certain personnel qualifications; Fi- nal rule[ J]. Federal Register, 2003, 68 (16) : 3640 - 3714.
  • 8中国合格评定国家认可委员会.CNAS--CL02医学实验室质量和能力认可准则[z].北京,2013.
  • 9Clinical And Laboratory Standards Institute (CLSI). EP5 - A2 E- valuation of precision performance of quantitative measurement methods ; approved guideline - second edition [ S ]. USA : CLSI, 2004.
  • 10National Committee for Clinical Laboratory Standards (NCCLS). EP9 - A2 Method comparison and bias estimation using patient sam- ples ; approved guideline - second edition [ S ]. USA : NCCLS, 2002.

共引文献64

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部